Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar protein sorting-associated protein 33B (VPS33B) is a member of the Sec1/Munc18 family and a component of the endolysosomal protein trafficking machinery. It is predominantly associated with late endosomes and lysosomes where it plays a critical role in mediating membrane fusion events required for proper endocytic and protein sorting pathways in mammalian cells. VPS33B is essential for the fusion of late endosomes with lysosomes, recycling of apical proteins especially in polarized cells, and biogenesis of platelet alpha-granules. Mutations in VPS33B are known to cause ARC syndrome, characterized by arthrogryposis, renal dysfunction, and cholestasis. In addition, it has negative regulatory effects on proliferation in some cancer cells. VPS33B functions through its involvement in the HOPS complex, necessary for vesicle tethering and membrane docking in endolysosomal transport processes[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting-associated protein 33B (VPS33B).